Choosing the most appropriate minimally invasive approach to treat gynecologic cancers in the context of an enhanced recovery program: Insights from a comprehensive cancer center.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2020
Historique:
received: 12 01 2020
accepted: 31 03 2020
entrez: 24 4 2020
pubmed: 24 4 2020
medline: 22 7 2020
Statut: epublish

Résumé

The aim of the study was to compare the characteristics of procedures for gynecologic cancers conducted with conventional laparoscopy (CL) or robotically assisted laparoscopy (RAL) in the context of an enhanced recovery program (ERP). This is a secondary analysis of prospectively collected data from a cohort study conducted between 2016 (when the ERP was first implemented at the Institut Paoli-Calmettes, a comprehensive cancer center in France) and 2018. We included patients who had undergone minimally invasive surgery for gynecological cancers and followed our ERP. The endpoints were the analysis of postoperative complications, the length of postoperative hospitalization (LPO), and the proportion of combined procedures depending on the approach (RAL or CL). Combined procedures were defined by the association of at least two of the following operative items: hysterectomy, pelvic lymphadenectomy, and para-aortic lymphadenectomy. A total of 362 women underwent either CL (n = 187) or RAL (n = 175) for gynecologic cancers and followed our ERP. The proportion of combined procedures performed by RAL was significantly higher (85/175 [48.6%]) than that performed by CL (23/187 [12.3%]; p < 0.001). The proportions of postoperative complications were similar between the two groups (19.4% versus 17.1%; p = 0.59). Logistic regression analysis revealed a statistically insignificant trend in the association of RAL with a reduced likelihood of an LPO > 3 days after adjusting for predictors of prolonged hospitalization (adjusted OR = 0.573 [0.236-1.388]; p = 0.217). Experts from our cancer center preferentially choose RAL to perform gynecologic oncological procedures that present elements of complexity. More studies are needed to determine whether this strategy is efficient in managing complex procedures in the framework of an ERP.

Identifiants

pubmed: 32324762
doi: 10.1371/journal.pone.0231793
pii: PONE-D-20-01006
pmc: PMC7179891
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0231793

Déclaration de conflit d'intérêts

We have read the journal's policy and the authors of this manuscript have the following competing interests: Eric Lambaudie and Gilles Houvenaeghel are proctors for Intuitive Surgical. Other authors have nothing to disclose. This does not alter our adherence to PLOS ONE policies on sharing data and materials.

Références

BMC Surg. 2017 Dec 28;17(1):136
pubmed: 29282059
Curr Treat Options Oncol. 2017 Aug 24;18(10):58
pubmed: 28840513
Ann Surg. 2011 Dec;254(6):868-75
pubmed: 21597360
Updates Surg. 2017 Mar;69(1):29-34
pubmed: 28188573
Hum Fertil (Camb). 2018 Apr;21(1):35-38
pubmed: 28625095
Gynecol Oncol. 2016 Feb;140(2):313-22
pubmed: 26603969
Obstet Gynecol Clin North Am. 2016 Sep;43(3):551-73
pubmed: 27521884
Gynecol Oncol. 2012 Feb;124(2):180-4
pubmed: 22079679
Surg Endosc. 2017 Jan;31(1):185-192
pubmed: 27139704
Br J Surg. 2015 Jan;102(2):e15-28
pubmed: 25627128
J Reprod Infertil. 2017 Apr-Jun;18(2):261-263
pubmed: 28868252
Gynecol Oncol. 2016 Feb;140(2):323-32
pubmed: 26757238
J Surg Educ. 2015 Jul-Aug;72(4):592-9
pubmed: 25687957
Ecancermedicalscience. 2017 Feb 08;11:ed62
pubmed: 28275393
Am J Obstet Gynecol. 2008 Nov;199(5):541.e1-7
pubmed: 18513685
Lancet. 2003 Dec 6;362(9399):1921-8
pubmed: 14667752
Am J Obstet Gynecol. 2016 Nov;215(5):588.e1-588.e7
pubmed: 27288987
JAMA Surg. 2017 Mar 1;152(3):292-298
pubmed: 28097305
Int J Med Robot. 2016 Mar;12(1):145-54
pubmed: 25823530
J Minim Invasive Gynecol. 2014 May-Jun;21(3):353-61
pubmed: 24295923
Gynecol Oncol. 2016 May;141(2):371-378
pubmed: 26906066
Surg Endosc. 2020 May;34(5):1985-1993
pubmed: 31309314
Ann Surg. 2009 Aug;250(2):187-96
pubmed: 19638912
Anesthesiol Clin. 2015 Mar;33(1):173-207
pubmed: 25701935
Am J Surg. 2002 Jun;183(6):630-41
pubmed: 12095591
J Minim Invasive Gynecol. 2016 Mar-Apr;23(3):309-16
pubmed: 26538410
Gynecol Oncol. 2015 Aug;138(2):457-71
pubmed: 26056752
J Minim Invasive Gynecol. 2017 Mar - Apr;24(3):379-396
pubmed: 28104497
Curr Opin Obstet Gynecol. 2015 Aug;27(4):302-7
pubmed: 26134173
J Clin Epidemiol. 1994 Nov;47(11):1245-51
pubmed: 7722560
N Engl J Med. 2018 Nov 15;379(20):1895-1904
pubmed: 30380365

Auteurs

Antoine Netter (A)

Department of Surgical Oncology, Aix-Marseille Univ, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Marseille, France.
Department of Obstetrics and Gynecology, Assistance Publique Hôpitaux de Marseille, La Conception Hospital, Aix Marseille University, Marseille, France.
Institut Méditerranéen de Biodiversité et d'Écologie marine et continentale (IMBE), Aix Marseille University, CNRS, IRD, Avignon University, Marseille, France.

Camille Jauffret (C)

Department of Surgical Oncology, Aix-Marseille Univ, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Marseille, France.

Clément Brun (C)

Département d'Anesthésie Réanimation, Institut Paoli Calmettes et CRCM, Marseille, France.

Laura Sabiani (L)

Department of Surgical Oncology, Aix-Marseille Univ, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Marseille, France.

Guillaume Blache (G)

Department of Surgical Oncology, Aix-Marseille Univ, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Marseille, France.

Gilles Houvenaeghel (G)

Department of Surgical Oncology, Aix-Marseille Univ, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Marseille, France.

Eric Lambaudie (E)

Department of Surgical Oncology, Aix-Marseille Univ, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, Marseille, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH